Literature DB >> 8896989

Mitochondrial diabetes mellitus.

A Rötig1, J P Bonnefont, A Munnich.   

Abstract

In the last few years, several mitochondrial DNA mutations and deletions have been described in association with various human diseases. Mitochondrial disorders, though long regarded strictly as neuromuscular diseases, may in fact involve non-neuromuscular symptoms. Diabetes mellitus has been reported in patients presenting with large mtDNA rearrangements (deletion, deletion-duplication) or in association with mtDNA point mutations, generally in tRNA genes (tRNA(Leu(UUR)). Genetic studies have shown that these disorders occur in sporadic cases or can be maternally inherited. The main clinical feature of mitochondrial diabetes is its nearly-consistent association with other symptoms (deafness, neurologic disorders, cardiac failure, renal failure, etc.). This paper provides a review of different types of mtDNA abnormalities associated with diabetes and a study of the prevalence of mitochondrial diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896989

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  10 in total

1.  Pir1p mediates translocation of the yeast Apn1p endonuclease into the mitochondria to maintain genomic stability.

Authors:  R Vongsamphanh; P K Fortier; D Ramotar
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Maternal and paternal family history of type 2 diabetes differently influence lipid parameters in young nondiabetic Japanese women.

Authors:  Kemal Sasaki; Aya Yoshida; Hiroshi Ohta; Yoshiharu Aizawa; Akiko Kojima; Hitomi Chiba; Shin Mizuguchi; Tatsunori Ishidzuka; Hiroshi Goto; Chiho Uegaki; Kyuhei Kotake
Journal:  Environ Health Prev Med       Date:  2012-07-25       Impact factor: 3.674

Review 3.  Strength training as a countermeasure to aging muscle and chronic disease.

Authors:  Ben F Hurley; Erik D Hanson; Andrew K Sheaff
Journal:  Sports Med       Date:  2011-04-01       Impact factor: 11.136

4.  Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.

Authors:  S Zhong; M C Ng; Y M Lo; J C Chan; P J Johnson
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

5.  Endocrinological and metabolic characteristics in patients who are non-obese and have polycystic ovary syndrome and different types of a family history of type 2 diabetes mellitus.

Authors:  Yuan Wang; Hua Gao; Wen Di; Zhuowei Gu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Oxidative stress induces degradation of mitochondrial DNA.

Authors:  Inna Shokolenko; Natalia Venediktova; Alexandra Bochkareva; Glenn L Wilson; Mikhail F Alexeyev
Journal:  Nucleic Acids Res       Date:  2009-03-05       Impact factor: 16.971

7.  Effect of Pimpinellatirupatiensison Oxidative Enzymes in STZ-induced Diabetic Rat Kidney.

Authors:  Saddala Rajeswarareddy; Thopireddy Lavany; Ganapathi Narasimhulu; Kesireddy Sathyavelureddy
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

8.  Mitochondrial complex I and V gene polymorphisms in type II diabetes mellitus among high risk Mizo-Mongoloid population, Northeast India.

Authors:  Freda Lalrohlui; Sunaina Thapa; Souvik Ghatak; John Zohmingthanga; Nachimuthu Senthil Kumar
Journal:  Genes Environ       Date:  2016-03-01

9.  Oxidative stress increases M1dG, a major peroxidation-derived DNA adduct, in mitochondrial DNA.

Authors:  Orrette R Wauchope; Michelle M Mitchener; William N Beavers; James J Galligan; Jeannie M Camarillo; William D Sanders; Philip J Kingsley; Ha-Na Shim; Thomas Blackwell; Thong Luong; Mark deCaestecker; Joshua P Fessel; Lawrence J Marnett
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

10.  Familial history of diabetes and clinical characteristics in Greek subjects with type 2 diabetes.

Authors:  Athanasia Papazafiropoulou; Alexios Sotiropoulos; Eystathios Skliros; Marina Kardara; Anthi Kokolaki; Ourania Apostolou; Stavros Pappas
Journal:  BMC Endocr Disord       Date:  2009-04-27       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.